Back
Day Range
$373.27
$383.14
52-Week Range
$373.26
$623.61
Volume
254,563
50D / 200D Avg
$435.41
/
$451.32
Prev Close
$377.99
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 19.9 | 0.4 |
| P/B | 5.4 | 2.9 |
| ROE % | 25.3 | 3.7 |
| Net Margin % | 10.5 | 3.8 |
| Rev Growth 5Y % | 4.3 | 10.0 |
| D/E | 0.2 | 0.2 |
Key Takeaways
Revenue grew 4.28% annually over 5 years — modest growth
Earnings declined -12.17% over the past year
ROE of 25.28% indicates high profitability
Debt/Equity of 0.16 — conservative balance sheet
Generating 325.48M in free cash flow
Cash machine — converts 122.71% of earnings into free cash flow
Growth
Revenue Growth (5Y)
4.28%
Revenue (1Y)4.06%
Earnings (1Y)-12.17%
FCF Growth (3Y)9.10%
Quality
Return on Equity
25.28%
ROIC22.37%
Net Margin10.48%
Op. Margin13.37%
Safety
Debt / Equity
0.16
Current Ratio1.05
Interest Coverage193.28
Valuation
P/E Ratio
19.86
P/B Ratio5.38
EV/EBITDA15.81
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 4.06% | Revenue Growth (3Y) | 5.70% |
| Earnings Growth (1Y) | -12.17% | Earnings Growth (3Y) | -1.34% |
| Revenue Growth (5Y) | 4.28% | Earnings Growth (5Y) | -0.31% |
| Profitability | |||
| Revenue (TTM) | 2.53B | Net Income (TTM) | 265.24M |
| ROE | 25.28% | ROA | 16.17% |
| Gross Margin | 29.97% | Operating Margin | 13.37% |
| Net Margin | 10.48% | Free Cash Flow (TTM) | 325.48M |
| ROIC | 22.37% | FCF Growth (3Y) | 9.10% |
| Safety | |||
| Debt / Equity | 0.16 | Current Ratio | 1.05 |
| Interest Coverage | 193.28 | Dividend Yield | 0.01% |
| Valuation | |||
| P/E Ratio | 19.86 | P/B Ratio | 5.38 |
| P/S Ratio | 2.08 | PEG Ratio | -2.78 |
| EV/EBITDA | 15.81 | Dividend Yield | 0.01% |
| Market Cap | 5.27B | Enterprise Value | 5.35B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2.53B | 2.43B | 2.26B | 2.13B | 2.14B |
| Net Income | 265.24M | 302.00M | 272.51M | 249.62M | 268.55M |
| EPS (Diluted) | 18.42 | 19.89 | 17.93 | 16.53 | 16.85 |
| Gross Profit | 758.34M | 854.35M | 798.82M | 765.09M | 769.80M |
| Operating Income | 338.25M | 366.49M | 340.57M | 343.50M | 343.04M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.64B | 1.67B | 1.67B | 1.44B | 1.34B |
| Total Liabilities | 660.61M | 549.58M | 560.22M | 643.30M | 719.45M |
| Shareholders' Equity | 979.41M | 1.12B | 1.11B | 798.72M | 623.27M |
| Total Debt | 154.76M | 140.84M | 155.11M | 247.01M | 323.54M |
| Cash & Equivalents | 74.52M | 178.35M | 263.96M | 74.13M | 32.90M |
| Current Assets | 302.62M | 394.75M | 500.84M | 272.61M | 230.29M |
| Current Liabilities | 287.13M | 285.70M | 312.05M | 297.21M | 302.40M |